Super protector.

Primary culprits of radiation-induced oropharyngeal mucositis are reactive oxygen species, such as superoxide anions (O2•-). Enter GC4419 which mimics our natural enzyme superoxide dismutase to add weight to our natural defenses aimed at clearing these high levels of radiation-induced superoxide anions before they can leave their mark. TBL: The superoxide dismutase mimetic GC4419 becomes the first drug to gain FDA approval for reduction of radiation-induced mucositis based on last month’s phase 1/2 results.